搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Serratia proteamaculans Cyanate hydratase (cynS) CSB-YP426678STJ
CSB-EP426678STJ
CSB-BP426678STJ
CSB-MP426678STJ
CSB-EP426678STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Deoxycytidine triphosphate deaminase (dcd) CSB-YP426679STJ
CSB-EP426679STJ
CSB-BP426679STJ
CSB-MP426679STJ
CSB-EP426679STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans ATP phosphoribosyltransferase (hisG) CSB-YP426680STJ
CSB-EP426680STJ
CSB-BP426680STJ
CSB-MP426680STJ
CSB-EP426680STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Translation initiation factor IF-1 (infA) CSB-YP426681STJ
CSB-EP426681STJ
CSB-BP426681STJ
CSB-MP426681STJ
CSB-EP426681STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Ribosome modulation factor (rmf) CSB-YP426682STJ
CSB-EP426682STJ
CSB-BP426682STJ
CSB-MP426682STJ
CSB-EP426682STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Methylglyoxal synthase (mgsA) CSB-YP426683STJ
CSB-EP426683STJ
CSB-BP426683STJ
CSB-MP426683STJ
CSB-EP426683STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans FMN reductase (NADH) RutF CSB-YP426684STJ
CSB-EP426684STJ
CSB-BP426684STJ
CSB-MP426684STJ
CSB-EP426684STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans UvrABC system protein C (uvrC) CSB-YP426685STJ
CSB-EP426685STJ
CSB-BP426685STJ
CSB-MP426685STJ
CSB-EP426685STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Phosphate acyltransferase (plsX) CSB-YP426686STJ
CSB-EP426686STJ
CSB-BP426686STJ
CSB-MP426686STJ
CSB-EP426686STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans UPF0227 protein Spro_1925 (Spro_1925) CSB-YP426687STJ
CSB-EP426687STJ
CSB-BP426687STJ
CSB-MP426687STJ
CSB-EP426687STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP426688STJ
CSB-EP426688STJ
CSB-BP426688STJ
CSB-MP426688STJ
CSB-EP426688STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans UPF0303 protein Spro_1996 (Spro_1996) CSB-YP426689STJ
CSB-EP426689STJ
CSB-BP426689STJ
CSB-MP426689STJ
CSB-EP426689STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Ribosomal RNA small subunit methyltransferase F (rsmF) CSB-YP426690STJ
CSB-EP426690STJ
CSB-BP426690STJ
CSB-MP426690STJ
CSB-EP426690STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans 50S ribosomal protein L20 (rplT) CSB-YP426691STJ
CSB-EP426691STJ
CSB-BP426691STJ
CSB-MP426691STJ
CSB-EP426691STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase (arnB) CSB-YP426692STJ
CSB-EP426692STJ
CSB-BP426692STJ
CSB-MP426692STJ
CSB-EP426692STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Lipoate-protein ligase A (lplA) CSB-YP426693STJ
CSB-EP426693STJ
CSB-BP426693STJ
CSB-MP426693STJ
CSB-EP426693STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Pyridoxine/pyridoxamine 5'-phosphate oxidase (pdxH) CSB-YP426694STJ
CSB-EP426694STJ
CSB-BP426694STJ
CSB-MP426694STJ
CSB-EP426694STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans Ribulokinase (araB), partial CSB-YP426695STJ
CSB-EP426695STJ
CSB-BP426695STJ
CSB-MP426695STJ
CSB-EP426695STJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans UPF0283 membrane protein Spro_2618 (Spro_2618), partial CSB-YP426696STJ1
CSB-EP426696STJ1
CSB-BP426696STJ1
CSB-MP426696STJ1
CSB-EP426696STJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Serratia proteamaculans UPF0259 membrane protein Spro_2675 (Spro_2675), partial CSB-YP426697STJ1
CSB-EP426697STJ1
CSB-BP426697STJ1
CSB-MP426697STJ1
CSB-EP426697STJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>